Garda Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,038	Closed	-$668K	–	197
2025 Q1	$668K	Buy	+6,038	New	+$668K	0.02%	69